Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,495.21
(
-1.47%
)
US TECH 100
23,052.80
(
-1.96%
)
Dow Jones
46,020.20
(
-0.88%
)
Brent Oil
102.53
(
3.80%
)
Bitcoin
68,353.21
(
-4.14%
)
News Focus
News Focus
Post# of 257293
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122814
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 1711

Thursday, 05/06/2004 1:49:18 PM

Thursday, May 06, 2004 1:49:18 PM

Post# of 257293
Re: The crowded cancer market:

#msg-2789976 listed some of the cancer drugs in development, and it’s a long list indeed. Today, a report from Research and Markets Ltd. (whom I’d never heard of) says that there are 114 drugs just in the anti-angiogenesis/VTA categories. [Thanks to Strawgold for the find.]

http://biz.yahoo.com/bw/040506/65647_1.html

>>
We have identified a total of 114 different therapies developed utilizing an antiangiogenetic or vascular targeting strategy.
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today